Severe acute respiratory syndrome‐coronavirus‐2: Current advances in therapeutic targets and drug development
出版年份 2020 全文链接
标题
Severe acute respiratory syndrome‐coronavirus‐2: Current advances in therapeutic targets and drug development
作者
关键词
-
出版物
REVIEWS IN MEDICAL VIROLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-09-23
DOI
10.1002/rmv.2174
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics
- (2020) David Gurwitz DRUG DEVELOPMENT RESEARCH
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
- (2020) Calvin J Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
- (2020) Jasper Fuk-Woo Chan et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
- (2020) Guangdi Li et al. NATURE REVIEWS DRUG DISCOVERY
- Characterization of Ebola convalescent plasma donor immune response and psoralen treated plasma in the United States
- (2020) Christina L. Dean et al. TRANSFUSION
- Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
- (2020) Xiaolong Tian et al. Emerging Microbes & Infections
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
- (2020) Nature Microbiology
- The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
- (2020) Stephen A. Lauer et al. ANNALS OF INTERNAL MEDICINE
- Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2
- (2020) Sairaj Satarker et al. ARCHIVES OF MEDICAL RESEARCH
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
- (2020) Evangelos J. Giamarellos-Bourboulis et al. Cell Host & Microbe
- Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
- (2020) Shuai Xia et al. CELL RESEARCH
- Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System
- (2020) Mahmoud Gheblawi et al. CIRCULATION RESEARCH
- Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
- (2020) Daniel Batlle et al. CLINICAL SCIENCE
- The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
- (2020) Paolo Verdecchia et al. European Journal of Internal Medicine
- In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel
- (2020) Manoj Kumar Gupta et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Role of Nonstructural Proteins in the Pathogenesis of SARS-CoV-2
- (2020) Severino Jefferson Ribeiro da Silva et al. JOURNAL OF MEDICAL VIROLOGY
- Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant
- (2020) Maria Pachetti et al. Journal of Translational Medicine
- Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
- (2020) Dora Pinto et al. NATURE
- Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur
- (2020) Zhenming Jin et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
- (2020) Shibo Jiang et al. TRENDS IN IMMUNOLOGY
- Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy
- (2020) Bhupesh Goyal et al. ACS Combinatorial Science
- TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention?
- (2020) Konrad H. Stopsack et al. Cancer Discovery
- Type 1 interferons as a potential treatment against COVID-19
- (2020) Erwan Sallard et al. ANTIVIRAL RESEARCH
- Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019—a multi-centre observational study
- (2020) Y. Cen et al. CLINICAL MICROBIOLOGY AND INFECTION
- SARS-CoV-2 and diabetes: New challenges for the disease
- (2020) Cecília Cristelo et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis
- (2020) Leiwen Fu et al. JOURNAL OF INFECTION
- The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development
- (2020) Noton K. Dutta et al. JOURNAL OF VIROLOGY
- ACE2 and COVID-19 and the resulting ARDS
- (2020) Xiaoqing Zhang et al. POSTGRADUATE MEDICAL JOURNAL
- Identifying airborne transmission as the dominant route for the spread of COVID-19
- (2020) Renyi Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ACE2, Much More Than Just a Receptor for SARS-COV-2
- (2020) Lobelia Samavati et al. Frontiers in Cellular and Infection Microbiology
- The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions
- (2020) Tapan Behl et al. LIFE SCIENCES
- Computational evaluation of major components from plant essential oils as potent inhibitors of SARS-CoV-2 spike protein
- (2020) Seema A. Kulkarni et al. JOURNAL OF MOLECULAR STRUCTURE
- TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection
- (2019) Naoko Iwata-Yoshikawa et al. JOURNAL OF VIROLOGY
- A Cysteine Protease Inhibitor Rescues Mice from a Lethal Cryptosporidium parvum Infection
- (2013) Momar Ndao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects
- (2013) Manuel Haschke et al. CLINICAL PHARMACOKINETICS
- Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential
- (2011) Melissa M. Coughlin et al. REVIEWS IN MEDICAL VIROLOGY
- A Small-Molecule Oxocarbazate Inhibitor of Human Cathepsin L Blocks Severe Acute Respiratory Syndrome and Ebola Pseudotype Virus Infection into Human Embryonic Kidney 293T cells
- (2010) P. P. Shah et al. MOLECULAR PHARMACOLOGY
- The renin angiotensin system and the metabolic syndrome
- (2010) Annette D. de Kloet et al. PHYSIOLOGY & BEHAVIOR
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now